Datatrak International Inc (DTRK) investors sentiment decreased to 1.14 in 2017 Q3. It’s down -0.64, from 1.78 in 2017Q2. The ratio turned negative, as 105 hedge funds increased or started new equity positions, while 92 sold and trimmed holdings in Datatrak International Inc. The hedge funds in our database now own: 63.84 million shares, up from 60.01 million shares in 2017Q2. Also, the number of hedge funds holding Datatrak International Inc in top ten equity positions decreased from 7 to 5 for a decrease of 2. Sold All: 28 Reduced: 64 Increased: 57 New Position: 48.
Equity Bancshares, Inc. (EQBK) formed double top with $39.09 target or 9.00% above today’s $35.86 share price. Equity Bancshares, Inc. (EQBK) has $438.71M valuation. The stock increased 0.79% or $0.28 during the last trading session, reaching $35.86. About 46,118 shares traded. Equity Bancshares, Inc. (NASDAQ:EQBK) has risen 37.05% since February 12, 2017 and is uptrending. It has outperformed by 20.35% the S&P500.
The stock increased 15.38% or $1 during the last trading session, reaching $7.5. About shares traded. DATATRAK International, Inc. (DTRK) has 0.00% since February 12, 2017 and is . It has underperformed by 16.70% the S&P500.
DATATRAK International, Inc., a technology and services company, provides unified clinical solutions and related services for the clinical trials industry. The company has market cap of $9.59 million. The firm offers DATATRAK ONE Unified Experience, a clinical enterprise solution that allows clinical users and service providers to design, deliver, and manage clinical trials. It currently has negative earnings. The Company’s products include UX CTMS 360 for planning and managing trials; UX Trial to streamline design-to-deployment process using a tool; UX EDC & Medical Coding for capturing and delivering data; UX Randomization and Trial Supply Management to randomize patients and automate supply; UX Patient Data Capture; UX Safety; and UX Training to train users and track certificates.
Among 3 analysts covering Equity Bancshares (NASDAQ:EQBK), 3 have Buy rating, 0 Sell and 0 Hold. Therefore 100% are positive. Equity Bancshares has $40 highest and $25 lowest target. $30.67’s average target is -14.47% below currents $35.86 stock price. Equity Bancshares had 4 analyst reports since December 7, 2015 according to SRatingsIntel. The stock of Equity Bancshares, Inc. (NASDAQ:EQBK) has “Market Perform” rating given on Monday, December 7 by Keefe Bruyette & Woods. The stock of Equity Bancshares, Inc. (NASDAQ:EQBK) has “Outperform” rating given on Friday, July 29 by Keefe Bruyette & Woods. The firm has “Outperform” rating given on Tuesday, January 10 by FBR Capital. The company was initiated on Monday, December 7 by Stephens.